Protective Effects of IL18-105G > A and IL18-137C > G Genetic Variants on Severity of COVID-19
Mayara Tiemi Enokida Mori,Andrea Name Colado Simao,Tiago Danelli,Sayonara Rangel Oliveira,Pedro Luis Candido de Souza Cassela,Guilherme Lerner Trigo,Kaue Morais Cardoso,Alexandre Mestre Tejo,Zuleica Naomi Tano,Elaine Regina Delicato de Almeida,Edna Maria Vissoci Reiche,Michael Maes,Marcell Alysson Batisti Lozovoy
DOI: https://doi.org/10.1016/j.cyto.2023.156476
IF: 3.926
2024-01-01
Cytokine
Abstract:Objective and Design: A cross-sectional study evaluated the IL18-105G > A (rs360717) and IL18-137C > G (rs187238) variants on Coronavirus Disease 2019 (COVID-19) severity. Subjects and Methods: 528 patients with COVID-19 classifed with mild (n = 157), moderate (n = 63) and critical (n = 308) disease were genotpyed for the IL18-105G > A and IL18-137C > G variants. Results: We observed associations between severe + critical COVID-19 groups (reference group was mild COVID19) and the IL18-105G > A (p = 0.008) and IL18-137C > G (p = 0.01) variants, which remained significant after adjusting for sex, ethnicity and age. Consequently, we have examined the associations between moderate + critical COVID-19 and the genotypes of both variants using different genetic models. The IL18-105G > A was associated with severe disease (moderate + critical), with effects of the GA genotype in the codominant [Odds ratio (OR), (95 % confidence interval) 0.55, 0.34-0.89, p = 0.015], overdominant (0.56, 0.35-0.89, p = 0.014) and dominant (0.60, 0.38-0.96, p = 0.031) models. IL18-105 GA coupled with age, chest computed tomograhy scan anormalities, body mass index, heart diseases, type 2 diabetes mellitus, hypertension, and inflammation may be used to predict the patients who develop severe disease with an accuracy of 84.3 % (sensitivity: 83.3 % and specificity: 86.5 %). Therefore, the presence of the IL18-105 A allele in homozygosis or heterozygosis conferred about 44.0 % of protection in the development of moderate and severe COVID-19. The IL18-137C > G variant was also associated with protective effects in the codominant (0.55, 0.34-0.89, p = 0.015), overdominant (0.57, 0.36-0.91, p = 0.018), and dominant models (0.59, 0.37-0.93, p = 0.025). Therefore, the IL18-137 G allele showed a protective effect against COVID-19 severity. Conclusion: The IL18-105G > A and IL18-137C > G variants may contribute with protective effects for COVID-19 severity and the effects of IL18-137C > G may be modulating IL-18 production and Th1-mediated immune responses.